This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, S.-W. Articles by Park, S.-J. Search for Related Content PubMed Articles by Lee, S.-W. Articles by Park, S.-J. Related Collections Related Article

A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus

Seung-Whan Lee, MD, PhD^_*, Seong-Wook Park, MD, PhD, FACC^_*,_*, Young-Hak Kim, MD, PhD^_*, Sung-Cheol Yun, PhD^_*, Duk-Woo Park, MD, PhD^_*, Cheol Whan Lee, MD, PhD^_*, Myeong-Ki Hong, MD, PhD^_*, Kyoung-Suk Rhee, MD, PhD, Jei Keon Chae, MD, PhD, Jae-Ki Ko, MD, PhD, Jae-Hyeong Park, MD, PhD, Jae-Hwan Lee, MD, PhD, Si Wan Choi, MD, Jin-Ok Jeong, MD, PhD, In-Whan Seong, MD, PhD, Yoon Haeng Cho, MD, PhD, Nae-Hee Lee, MD, PhD, June Hong Kim, MD, PhD^||, Kook-Jin Chun, MD^||, Hyun-Sook Kim, MD, PhD^¶ and Seung-Jung Park, MD, PhD, FACC^_*

^_* Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Chonbuk National University Hospital, Jeonju, Korea
Cardiology Division of Internal Medicine, Chungnam National University Hospital, Chungnam National University, Deajeon, Korea
Soonchunhyang University Bucheon Hospital, Bucheon, Korea
^|| Busan National University Hospital, Busan, Korea
^¶ Hallym University Sacred Heart Hospital, Anyang, Korea.

View larger version (13K): [in this window] [in a new window] [Download PPT slide]   Figure 1 The In-Segment Restenosis Rate According to Drug-Eluting Stent and Use of Cilostazol There is interaction between the type of drug-eluting stent and use of cilostazol for in-segment restenosis (p < 0.001). Although there was significant difference in relative measure of in-segment restenosis rate due to 0% in-segment restenosis rate of the sirolimus-eluting stent + cilostazol group, the absolute measure was not statistically different (p = 0.861).